Searchable abstracts of presentations at key conferences in endocrinology

ea0056p612 | Thyroid cancer | ECE2018

A case of diabetic patient with recurrent ketosis after U-300 glargine treatment

Ulasli Tugce , Gungunes Askin , Durmaz Senay Arikan

Introduction: U-300 glargine is a new generation long acting insulin. Nocturnal hypoglicemia and weight gain with U-300 glargine is lower than U-100 glargine. However, it may take 3–4 days for U-300 glargine to reach stable state in plasma. We report a diabetic case with recurrent ketosis after U-300 glargine.Case presentation: A 20 years old woman with type 1 diabetes mellitus who uses basal and bolus insulin (U-300 glargine and insülin aspart...